{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T02:52:00Z","timestamp":1773024720225,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.thromres.2021.10.005","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T01:01:12Z","timestamp":1634259672000},"page":"26-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Thrombolytic and anticoagulant effects of a recombinant staphylokinase-hirudin fusion protein"],"prefix":"10.1016","volume":"208","author":[{"given":"Keyun","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoyan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lvming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chutse","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2021.10.005_bb0005","article-title":"Thromboembolism in older adults","volume":"7","author":"Gross","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.thromres.2021.10.005_bb0010","first-page":"100788","article-title":"Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review","author":"Cheng","year":"2020","journal-title":"Blood Rev."},{"issue":"15","key":"10.1016\/j.thromres.2021.10.005_bb0015","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1161\/CIRCULATIONAHA.108.841403","article-title":"Cardiology patient pages. The surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism","volume":"119","author":"Rathbun","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2021.10.005_bb0020","article-title":"Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis","volume":"78","author":"Rosendaal","year":"1997","journal-title":"Thromb. Haemost."},{"issue":"15","key":"10.1016\/j.thromres.2021.10.005_bb0025","first-page":"1665","article-title":"Deep vein thrombosis and pulmonary embolism in the general population. 'The study of men born in 1913'","volume":"157","author":"Hansson","year":"1997"},{"issue":"3","key":"10.1016\/j.thromres.2021.10.005_bb0030","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1378\/chest.122.3.960","article-title":"Deep venous thrombosis in a general hospital","volume":"122","author":"Stein","year":"2002","journal-title":"Chest"},{"issue":"15","key":"10.1016\/j.thromres.2021.10.005_bb0035","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.2018.14346","article-title":"Venous thromboembolism: advances in diagnosis and treatment","volume":"320","author":"Tritschler","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.thromres.2021.10.005_bb0040","first-page":"310","article-title":"Direct oral anticoagulants for treatment of deep vein thrombosis: overview of systematic reviews","volume":"17","author":"Brandao","year":"2018","journal-title":"J. Vasc. Bras."},{"key":"10.1016\/j.thromres.2021.10.005_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.avsg.2018.12.067","article-title":"Endovascular management of acute lower limb deep vein thrombosis: a systematic review and meta-analysis","volume":"58","author":"Thomas","year":"2019","journal-title":"Ann Vasc Surg."},{"key":"10.1016\/j.thromres.2021.10.005_bb0050","doi-asserted-by":"crossref","first-page":"102190","DOI":"10.1016\/j.ctrv.2021.102190","article-title":"Treatment of venous thromboembolism in cancer patients: The dark side of the moon","volume":"96","author":"Becattini","year":"2021","journal-title":"Cancer Treat Rev."},{"issue":"2","key":"10.1016\/j.thromres.2021.10.005_bb0055","first-page":"409","article-title":"Management of Patients with Venous Thromboembolism after the initial treatment period","volume":"34","author":"Fernandes","year":"2021"},{"issue":"22","key":"10.1016\/j.thromres.2021.10.005_bb0060","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM199311253292204","article-title":"The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction","volume":"329","author":"Investigators","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.thromres.2021.10.005_bb0065","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJM199011223232110","article-title":"Conjunctive antithrombotic and thrombolytic therapy for coronary-artery occlusion","volume":"323","author":"Gold","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2021.10.005_bb0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1432-1033.1995.350_c.x","article-title":"Functional properties of a recombinant chimeric protein with combined thrombin inhibitory and plasminogen-activating potential","volume":"234","author":"Lijnen","year":"1995","journal-title":"Eur. J. Biochem."},{"issue":"6","key":"10.1016\/j.thromres.2021.10.005_bb0075","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjh.14714","article-title":"Current challenges and future prospects in oral anticoagulant therapy","volume":"178","author":"Czuprynska","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2021.10.005_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000348705","article-title":"Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities","volume":"35","author":"Rother","year":"2013","journal-title":"Cerebrovasc. Dis."},{"issue":"7","key":"10.1016\/j.thromres.2021.10.005_bb0085","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1160\/TH16-10-0823","article-title":"Venous thromboembolism: past, present and future","volume":"117","author":"Schulman","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2021.10.005_bb0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2002-35292","article-title":"Hirudin as alternative anticoagulant\u2013a historical review","volume":"28","author":"Markwardt","year":"2002","journal-title":"Semin. Thromb. Hemost."},{"issue":"21","key":"10.1016\/j.thromres.2021.10.005_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217975","article-title":"Factors affecting the formation and treatment of thrombosis by natural and synthetic compounds","volume":"21","author":"Lichota","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.thromres.2021.10.005_bb0100","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.RES.72.5.1091","article-title":"Comparison of hirudin and heparin as adjuncts to streptokinase thrombolysis in a canine model of coronary thrombosis","volume":"72","author":"Rigel","year":"1993","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.thromres.2021.10.005_bb0105","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/01.CIR.93.4.792","article-title":"Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin","volume":"93","author":"Mruk","year":"1996","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.thromres.2021.10.005_bb0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/01.CIR.97.7.681","article-title":"Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin","volume":"97","author":"Meyer","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.thromres.2021.10.005_bb0115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.94.5.863","article-title":"Thrombin inhibitors in fibrinolysis. A Hobson's choice of alternatives","volume":"94","author":"Loscalzo","year":"1996","journal-title":"Circulation"},{"issue":"3 Suppl","key":"10.1016\/j.thromres.2021.10.005_bb0120","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"issue":"3 Suppl","key":"10.1016\/j.thromres.2021.10.005_bb0125","doi-asserted-by":"crossref","first-page":"549S","DOI":"10.1378\/chest.126.3_suppl.549S","article-title":"Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Menon","year":"2004","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.thromres.2021.10.005_bb0130","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1182\/blood.V78.12.3114.3114","article-title":"Basic and clinical aspects of fibrinolysis and thrombolysis","volume":"78","author":"Collen","year":"1991","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.thromres.2021.10.005_bb0135","doi-asserted-by":"crossref","first-page":"46G","DOI":"10.1016\/0002-9149(93)90107-N","article-title":"On the future of thrombolytic therapy for acute myocardial infarction","volume":"72","author":"Collen","year":"1993","journal-title":"Am. J. Cardiol."},{"issue":"24","key":"10.1016\/j.thromres.2021.10.005_bb0140","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1053\/euhj.2000.2498","article-title":"Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction","volume":"21","author":"In T-III","year":"2000","journal-title":"Eur Heart J."},{"issue":"2","key":"10.1016\/j.thromres.2021.10.005_bb0145","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/STROKEAHA.116.015414","article-title":"Is unexplained early neurological deterioration after intravenous thrombolysis associated with thrombus Extension?","volume":"48","author":"Seners","year":"2017","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.thromres.2021.10.005_bb0150","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/01.CIR.88.3.1361","article-title":"Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?","volume":"88","author":"Lincoff","year":"1993","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2021.10.005_bb0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0897190018767769","article-title":"Systemic thrombolytic therapy for massive and submassive pulmonary embolism","volume":"33","author":"Igneri","year":"2020","journal-title":"J. Pharm. Pract."},{"issue":"6","key":"10.1016\/j.thromres.2021.10.005_bb0160","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1160\/TH06-10-0562","article-title":"A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity - a staphylokinase variant. An in-vivo study","volume":"97","author":"Szemraj","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.10.005_bb0165","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ijbiomac.2019.09.191","article-title":"Construction of a novel staphylokinase (SAK) mutant with low immunogenicity and its evaluation in rhesus monkey","volume":"146","author":"Wang","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.thromres.2021.10.005_bb0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0049-3848(85)90023-4","article-title":"Assay of hirudin in plasma using a chromogenic thrombin substrate","volume":"37","author":"Griessbach","year":"1985","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2021.10.005_bb0175","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/ATVBAHA.109.185678","article-title":"Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats","volume":"29","author":"Zhou","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.thromres.2021.10.005_bb0180","first-page":"550","article-title":"Photochemically induced thrombosis of the rat coronary artery and functional evaluation of thrombus formation by occurrence of ventricular arrhythmias. Effects of acetylsalicylic acid and a thromboxane A2 synthetase inhibitor of thrombus formation","volume":"346","author":"Fukuchi","year":"1992"},{"issue":"1\u20132","key":"10.1016\/j.thromres.2021.10.005_bb0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2003.08.012","article-title":"Differential effects of sodium nitroprusside and hydralazine in a rat model of topical FeCl3-induced carotid artery thrombosis","volume":"111","author":"Robinson","year":"2003","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2021.10.005_bb0190","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0049-3848(80)90249-2","article-title":"Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents","volume":"17","author":"Romson","year":"1980","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.thromres.2021.10.005_bb0195","first-page":"1955","article-title":"Two characteristics of a recombinant fusion protein composed of staphylokinase and hirudin: high thrombus affinity and thrombus-targeting release ofanticoagulant activity","volume":"24","author":"Yu","year":"2008","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"10.1016\/j.thromres.2021.10.005_bb0200","series-title":"Study on the activity of recombinant mutant tissue-type plasminogen activator fused with the C-terminal fragment of hirudin","author":"Ren","year":"2021"},{"issue":"13","key":"10.1016\/j.thromres.2021.10.005_bb0205","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2174\/1389201019666180209121323","article-title":"Staphylokinase enzyme: an overview of structure, function and engineered forms","volume":"18","author":"Vakili","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"10.1016\/j.thromres.2021.10.005_bb0210","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11033-019-05167-x","article-title":"Bacterial staphylokinase as a promising third-generation drug in the treatment for vascular occlusion","volume":"47","author":"Nedaeinia","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.thromres.2021.10.005_bb0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/02648725.2018.1506898","article-title":"Hirudin variants production by genetic engineered microbial factory","volume":"34","author":"Zhang","year":"2018","journal-title":"Biotechnol. Genet. Eng. Rev."},{"issue":"5","key":"10.1016\/j.thromres.2021.10.005_bb0220","first-page":"419","article-title":"Production of a recombinant antithrombotic and fibrinolytic protein, PLATSAK, inEscherichia coli","volume":"88","author":"van Zyl","year":"1997"},{"issue":"5","key":"10.1016\/j.thromres.2021.10.005_bb0225","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0049-3848(00)00204-8","article-title":"PLATSAK, a potent antithrombotic and fibrinolytic protein, inhibits arterial and venous thrombosis in a baboon model","volume":"98","author":"van Zyl","year":"2000","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2021.10.005_bb0230","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/AEM.65.2.506-513.1999","article-title":"Staphylokinase as a plasminogen activator component in recombinant fusion proteins","volume":"65","author":"Szarka","year":"1999","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.thromres.2021.10.005_bb0235","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.csbj.2019.06.023","article-title":"Structural biology and protein engineering of thrombolytics","volume":"17","author":"Mican","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821004783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821004783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:46:02Z","timestamp":1758735962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384821004783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":47,"alternative-id":["S0049384821004783"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.10.005","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombolytic and anticoagulant effects of a recombinant staphylokinase-hirudin fusion protein","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}